Literature DB >> 7878208

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

B M Dubray1, H D Thames.   

Abstract

PURPOSE: Analysis of four different sets of experiments performed by the G.S.F. group in Munich investigating the late tolerance of the rat rectum to external or intracavitary irradiation.
MATERIAL AND METHODS: The endpoint was late rectal stenosis in female Wistar rats. The raw data were fitted to the linear-quadratic model by means of a likelihood maximization method (Direct Analysis). The model was altered to allow for repopulation, incomplete repair, and varying irradiated lengths of the rectum.
RESULTS: Fractionation sensitivity was high or intermediate (alpha/beta ratio values [95% confidence limits] ranging from 2.67 [0.86, 4.80] to 6.65 [2.21, 11.73] Gy). Significant repopulation occurred when treatments were longer than 5 days (Dprolif equal to 0.61 [0.20, 1.47] and 1.08 [0.58, 1.90] Gy/day, in fractions of 4 Gy). Another interpretation is that radiosensitivity changed during treatment. Repair half-time estimates ranged between 1.84 [1.52, 2.34] and 5.02 [2.83, 21.7] h. Finally, the present analysis indicated that the smallest surviving compartment capable of tissue rescue was about 1/50 to 1/100 of a 1 cm high cylinder of the rectum wall.
CONCLUSIONS: The radiobiological features of late stenosis in the rats are consistent with combined injuries of early and late responding components of the rectal wall. This raises some concerns about the possible danger of hyperfractionated treatments, where the beneficial impact of fraction size reduction may be obviated for interfraction intervals that are too short. Also, accelerated irradiation may result in more late complications because of increased early reactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7878208     DOI: 10.1016/0167-8140(94)90084-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.

Authors:  Katarzyna Behrendt; Elżbieta Nowicka; Marzena Gawkowska-Suwińska; Grzegorz Plewicki; Beata Smolska-Ciszewska; Monika Giglok; Rafał Suwiński; Aleksander Zajusz
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-15

2.  Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Authors:  Susan L Tucker; Howard D Thames; Jeff M Michalski; Walter R Bosch; Radhe Mohan; Kathryn Winter; James D Cox; James A Purdy; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

3.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.

Authors:  Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Andre A Konski; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; C-M Charlie Ma; Shawn W McNeeley; Mark K Buyyounouski; Robert A Price
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-19       Impact factor: 7.038

Review 4.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

5.  Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results.

Authors:  Maurizio Valeriani; Alessia Carnevale; Mattia Falchetto Osti; Vitaliana DE Sanctis; Linda Agolli; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2014-09-26       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.